ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation

Liu, Ming; Lu, Bingtai; Li, Yue; Yuan, Shuofeng; Zhuang, Zhen; Li, Guangyu; Wang, Dong; Ma, Liuheyi; Zhu, Jianheng; Zhao, Jinglu; Chan, Chris Chung-Sing; Poon, Vincent Kwok-Man; Chik, Kenn Ka-Heng; Zhao, Zhiyao; Xian, Huifang; Zhao, Jingxian; Zhao, Jincun*; Chan, Jasper Fuk-Woo*; Zhang, Yuxia*广东省人民医院; 广州医学院; 南方医科大学; 郑州大学; 1
Signal Transduction and Targeted Therapy2023-10-9DOI: 10.1038/s41392-023-01631-0
7阅读
引用收藏
分享

摘要

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has had a significant impact on healthcare systems and economies worldwide. The continuous emergence of new viral strains presents a major challenge in the development of effective antiviral agents. Strategies that possess broad-spectrum antiviral activities are desirable to control SARS-CoV-2 infection. ACE2, an angiotensin-containing enzyme that prevents the overactivation of the renin angiotensin system, is the receptor for SARS-CoV-2. ACE2 interacts with the spike protein and facilitates viral attachment and entry into host cells. Yet, SARS-CoV-2 infection also promotes ACE2 degradation. Whether restoring ACE2 surface expression has an impact on SARS-CoV-2 infection is yet to be determined. Here, we show that the ACE2-spike complex is endocytosed and degraded via autophagy in a manner that depends on clathrin-mediated endocytosis and PAK1-mediated cytoskeleton rearrangement. In contrast, free cellular spike protein is selectively cleaved into S1 and S2 subunits in a lysosomal-dependent manner. Importantly, we show that the pan-PAK inhibitor FRAX-486 restores ACE2 surface expression and suppresses infection by different SARS-CoV-2 strains. FRAX-486-treated Syrian hamsters exhibit significantly decreased lung viral load and alleviated pulmonary inflammation compared with untreated hamsters. In summary, our findings have identified novel pathways regulating viral entry, as well as therapeutic targets and candidate compounds for controlling the emerging strains of SARS-CoV-2 infection.

学科与关键词

关键词
CONVERTING ENZYMESPIKE PROTEINSARS-COVCORONAVIRUSRECEPTORBINDINGEXPRESSIONAXIS
相关
加载中…
  • Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy
    Jin, Shouheng*; He, Xing; Ma, Ling; Zhuang, Zhen; Wang, Yiliang; Lin, Meng; Cai, Sihui; Wei, Lu; Wang, Zheyu; Zhao, Zhiyao; Wu, Yaoxing; Sun, Lin; Li, Chunwei; Xie, Weihong; Zhao, Yong; Songyang, Zhou; Peng, Ke; Zhao, Jincun; Cui, Jun*Nature Communications, 2022, 13(1): 5204.被引 18
  • A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry
    Zhu, Yunkai; Feng, Fei; Hu, Gaowei; Wang, Yuyan; Yu, Yin; Zhu, Yuanfei; Xu, Wei; Cai, Xia; Sun, Zhiping; Han, Wendong; Ye, Rong; Qu, Di; Ding, Qiang; Huang, Xinxin; Chen, Hongjun; Xu, Wei; Xie, Youhua; Cai, Qiliang*; Yuan, Zhenghong*; Zhang, Rong*Nature Communications, 2021, 12(1): 961.被引 148
  • Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2
    Guo, Xuanming; Cao, Jianli; Cai, Jian-Piao; Wu, Jiayan; Huang, Jiangang; Asthana, Pallavi; Wong, Sheung Kin Ken; Ye, Zi-Wei; Gurung, Susma; Zhang, Yijing; Wang, Sheng; Wang, Zening; Ge, Xin; Kwan, Hiu Yee; Lyu, Aiping; Chan, Kui Ming; Wong, Nathalie; Huang, Jiandong; Zhou, Zhongjun; Bian, Zhao-Xiang; Yuan, Shuofeng*; Wong, Hoi Leong Xavier*Nature Communications, 2022, 13(1): 7907.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Signal Transduction and Targeted Therapy
发表日期
2023-10-09
卷期
第 8 卷, 第 1 期
页码
385
DOI
10.1038/s41392-023-01631-0
期刊收录
CAST-L
成果收录
SCIE
资助标注
This work was supported by the National Natural Science Foundation of China (NSFC; Nos. #82000007 to M.L., #82001676 and #91842304 to B.T.L., #82125015 to Y.X.Z., #82272337 to J.F.W.C.); the GWCMC Postdoc Fund (Nos. #5001-3001061 to M.L., #5001-3001060 to [82000007, 82001676, 91842304, 82125015, 82272337]; National Natural Science Foundation of China (NSFC) [5001-3001061, 5001-3001060]; GWCMC Postdoc Fund [2021YJC02]; Chongqing International Institute for Immunology [202102020194]; Guangzhou Basic and Applied Basic Research Fund for Young Ph.D. scientists [ZNSA-2020013]; Zhongnanshan Medical Foundation of Guangdong Province [17122322]; General Research Fund [SZSM201911014]; Sanming Project of Medicine in Shenzhen, China; Health Commission of Guangdong Province, China [EKPG22-01]; Emergency Collaborative Project

作者

  • L

    Liu, Ming (第一作者)

    guangzhou med univ · guangzhou women & childrens med ctr

  • L

    Lu, Bingtai

    guangdong prov peoples hosp · southern med univ

查看全部 19 位作者收起作者
  • L

    Li, Yue

    guangzhou med univ · guangzhou women & childrens med ctr

  • Y

    Yuan, Shuofeng

    univ hong kong

  • Z

    Zhuang, Zhen

    1 · guangzhou med univ

  • L

    Li, Guangyu

    guangzhou med univ · guangzhou women & childrens med ctr

  • W

    Wang, Dong

    1 · guangzhou med univ

  • M

    Ma, Liuheyi

    guangzhou med univ · guangzhou women & childrens med ctr

  • Z

    Zhu, Jianheng

    guangzhou med univ · guangzhou women & childrens med ctr

  • Z

    Zhao, Jinglu

    zhengzhou univ

  • C

    Chan, Chris Chung-Sing

    univ hong kong

  • P

    Poon, Vincent Kwok-Man

    univ hong kong

  • C

    Chik, Kenn Ka-Heng

    univ hong kong

  • Z

    Zhao, Zhiyao

    guangzhou med univ · guangzhou women & childrens med ctr

  • X

    Xian, Huifang

    guangzhou med univ · guangzhou women & childrens med ctr

  • Z

    Zhao, Jingxian

    1 · guangzhou med univ

  • Z

    Zhao, Jincun (通讯)

    1 · guangzhou med univ

  • C

    Chan, Jasper Fuk-Woo (通讯)

    univ hong kong

  • Z

    Zhang, Yuxia (通讯)

    zhengzhou univ · guangzhou med univ · guangzhou women & childrens med ctr

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417